Western Washington Oncology P S is categorized under Oncologists in Lacey, WA and active since 1986.
Western Washington Oncology P S was established in 1986, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Dr Dustan Osborn Md Phd at the company’s headquarters by writing to 4525 3rd Avenue Se, Lacey, Washington WA 98503 or by phoning (360) 412-8900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Western Washington Oncology P S |
| Contact Person: | Dr Dustan Osborn Md Phd |
| Address: | 4525 3rd Avenue Se, Lacey, Washington 98503 |
| Phone Number: | (360) 412-8900 |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Founded: | 1986 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Western Washington Oncology P S was started in 1986 to provide professional Oncologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Dr Dustan Osborn Md Phd for inquiries that concern Western Washington Oncology P S by calling the company number (360) 412-8900, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Western Washington Oncology P S can be found at the coordinates 47.045413,-122.825862 as well as the street address 4525 3rd Avenue Se in Lacey, Washington 98503.
For its online presence, you may visit Western Washington Oncology P S’s website at and engage with its social media outlets through on Twitter and on Facebook.